Amicus Therapeutics Announcement at Healthcare Conference
Amicus Therapeutics is excited to announce that Bradley Campbell, the President and Chief Executive Officer, will be presenting at the upcoming 43rd Annual J.P. Morgan Healthcare Conference. This notable event is set to take place in San Francisco, where leaders in the healthcare industry gather to share insights and advancements.
Event Details and Presentation Schedule
The presentation is scheduled for January 13, 2025, at 3:00 p.m. PT. This gathering serves as a vital platform for many companies to showcase their innovations and strategies, allowing investors and stakeholders to engage with the latest in biotechnology and healthcare.
Live Audio Webcast Access
To ensure that interested parties can attend the presentation remotely, Amicus Therapeutics will provide a live audio webcast of the event. Access to the webcast will be available through the investors section of their corporate website. This initiative reflects the company’s commitment to transparency and investor engagement.
About Amicus Therapeutics
Amicus Therapeutics is a patient-centric biotechnology company dedicated to developing high-quality therapies aimed at addressing unmet medical needs for rare diseases. The company emphasizes a strong connection with patients, ensuring that their research and development efforts are directly aligned with the needs of those they serve.
Pioneering Treatments for Rare Diseases
The organization is known for its cutting-edge approach in developing novel therapies. Amicus Therapeutics is continually advancing its pipeline of best-in-class medicines that open new possibilities for individuals facing rare diseases. As the landscape of healthcare evolves, Amicus stands out for its ingenuity and dedication to improving patient outcomes.
Commitment to Innovation
As part of its mission, Amicus Therapeutics is focused on innovating new treatments, thus enhancing patient quality of life. The company operates with a clear vision to bring forth therapies that are both effective and accessible to those in need.
Contact Information for Inquiries
For those looking for more information or needing to connect with Amicus Therapeutics:
Investor Relations Contact
Andrew Faughnan, Vice President of Investor Relations, is available for inquiries. Interested parties can reach out via email or phone to discuss investment opportunities and corporate updates.
Media Relations Contact
Diana Moore, Head of Global Corporate Affairs and Communications, can address media inquiries and provide insights into company developments. Communication channels are open to foster relationships with stakeholders and the public.
Frequently Asked Questions
What is the J.P. Morgan Healthcare Conference?
The J.P. Morgan Healthcare Conference is an annual event that gathers industry leaders to discuss advancements in healthcare and biotechnology.
How can I access the Amicus Therapeutics presentation?
The presentation can be accessed via a live audio webcast through the Amicus Therapeutics corporate website.
Who is presenting for Amicus Therapeutics?
Bradley Campbell, the President and CEO, will be the presenter at the event.
What does Amicus Therapeutics focus on?
Amicus Therapeutics is dedicated to developing therapies for rare diseases, emphasizing patient-centered innovation.
How can I contact Amicus Therapeutics for more information?
Contact can be made through their investor relations or media relations departments for any inquiries.
